β2-adrenergic signaling promotes higher-affinity B cells and antibodies.


Journal

Brain, behavior, and immunity
ISSN: 1090-2139
Titre abrégé: Brain Behav Immun
Pays: Netherlands
ID NLM: 8800478

Informations de publication

Date de publication:
10 2023
Historique:
received: 16 03 2023
revised: 28 05 2023
accepted: 22 06 2023
medline: 4 9 2023
pubmed: 28 6 2023
entrez: 27 6 2023
Statut: ppublish

Résumé

Stress-induced β2-adrenergic receptor (β2AR) activation in B cells increases IgG secretion; however, the impact of this activation on antibody affinity and the underlying mechanisms remains unclear. In the current study, we demonstrate that stress in mice following ovalbumin (OVA) or SARS-CoV-2 RBD immunization significantly increases both serum and surface-expressed IgG binding to the immunogen, while concurrently reducing surface IgG expression and B cell clonal expansion. These effects were abolished by pharmacological β2AR blocking or when the experiments were conducted in β2AR -/- mice. In the second part of our study, we used single B cell sorting to characterize the monoclonal antibodies (mAbs) generated following β2AR activation in cultured RBD-stimulated B cells from convalescent SARS-CoV-2 donors. Ex vivo β2AR activation increased the affinities of the produced anti-RBD mAbs by 100-fold compared to mAbs produced by the same donor control cultures. Consistent with the mouse experiments, β2AR activation reduced both surface IgG levels and the frequency of expanded clones. mRNA sequencing revealed a β2AR-dependent upregulation of the PI3K pathway and B cell receptor (BCR) signaling through AKT phosphorylation, as well as an increased B cell motility. Overall, our study demonstrates that stress-mediated β2AR activation drives changes in B cells associated with BCR activation and higher affinity antibodies.

Identifiants

pubmed: 37369341
pii: S0889-1591(23)00164-2
doi: 10.1016/j.bbi.2023.06.020
pii:
doi:

Substances chimiques

Adrenergic Agents 0
Phosphatidylinositol 3-Kinases EC 2.7.1.-
Receptors, Adrenergic, beta-2 0
Immunoglobulin G 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-82

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Noam Ben-Shalom (N)

Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, 6997801 Israel.

Elad Sandbank (E)

The School of Psychological Sciences, Tel Aviv University, 6997801, Israel.

Lilach Abramovitz (L)

Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, 6997801 Israel.

Hadas Hezroni (H)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

Talia Levine (T)

The School of Psychological Sciences, Tel Aviv University, 6997801, Israel.

Estherina Trachtenberg (E)

The Sagol School of Neurosciences, Gordon Faculty of Social Sciences, Tel Aviv University, Israel.

Nadav Fogel (N)

The School of Psychological Sciences, Tel Aviv University, 6997801, Israel.

Michael Mor (M)

Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, 6997801 Israel.

Ron Yefet (R)

Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, 6997801 Israel.

Liat Stoler-Barak (L)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

David Hagin (D)

Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, 6997801 Israel; Allergy and Clinical Immunology Unit, Department of Medicine, Tel Aviv Sourasky Medical Center, 623906, Israel.

Akiko Nakai (A)

Laboratory of Immune Response Dynamics, WPI Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan; Department of Immune Response Dynamics, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.

Masaki Noda (M)

Center for Stem Cell and Regenerative Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.

Kazuhiro Suzuki (K)

Laboratory of Immune Response Dynamics, WPI Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan; Department of Immune Response Dynamics, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka 565-0871, Japan.

Ziv Shulman (Z)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

Shamgar Ben-Eliyahu (S)

The School of Psychological Sciences, Tel Aviv University, 6997801, Israel; The Sagol School of Neurosciences, Gordon Faculty of Social Sciences, Tel Aviv University, Israel. Electronic address: shamgar@mail.tau.ac.il.

Natalia T Freund (NT)

Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, 6997801 Israel. Electronic address: nfreund@tauex.tau.ac.il.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH